Skip to main content

Table 2 Schedule of enrolment, interventions, and assessments

From: A placebo-controlled, crossover trial to investigate the efficacy of tiotropium bromide or placebo added to usual care in stable symptomatic post-hematopoietic stem cell transplantation (HSCT) bronchiolitis obliterans syndrome (BOS)

Back to article page

Trials

ISSN: 1745-6215